2016
DOI: 10.1186/s12864-016-3143-y
|View full text |Cite
|
Sign up to set email alerts
|

Mining kidney toxicogenomic data by using gene co-expression modules

Abstract: BackgroundAcute kidney injury (AKI) caused by drug and toxicant ingestion is a serious clinical condition associated with high mortality rates. We currently lack detailed knowledge of the underlying molecular mechanisms and biological networks associated with AKI. In this study, we carried out gene co-expression analyses using DrugMatrix—a large toxicogenomics database with gene expression data from rats exposed to diverse chemicals—and identified gene modules associated with kidney injury to probe the molecul… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 21 publications
(17 citation statements)
references
References 112 publications
(119 reference statements)
0
17
0
Order By: Relevance
“…As proof for the validity of our molecular interaction model, many of the (patho)physiological processes mediated by these cell surface-receptor complexes were described also in the context of AKI or its underlying disease conditions. [245][246][247][248][249][250][251][252] This also accounts for all other proteins included in the molecular interaction graph not involved in receptor signaling such as the flavin adenine dinucleotide-linked sulfhydryl oxidase ALR Q37 , for which renoprotective effects were described in ischemia/reperfusion, 253 the peptidylprolyl isomerase F, a mitochondrial protein found to be involved in ischemia/reperfusion-induced cell death, 254 the calcitonin gene-related peptide 2, a vasodilator that increases susceptibility to AKI, 255 and superoxide dismutase 3, an extracellular oxidoreductase that decreases oxidative stress and injury after ischemia/ reperfusion-induced AKI. 256 The connection of all gap-bridging proteins to AKI was interpreted as a sign for the high integrity of the molecular interaction graph.…”
Section: Q36mentioning
confidence: 99%
“…As proof for the validity of our molecular interaction model, many of the (patho)physiological processes mediated by these cell surface-receptor complexes were described also in the context of AKI or its underlying disease conditions. [245][246][247][248][249][250][251][252] This also accounts for all other proteins included in the molecular interaction graph not involved in receptor signaling such as the flavin adenine dinucleotide-linked sulfhydryl oxidase ALR Q37 , for which renoprotective effects were described in ischemia/reperfusion, 253 the peptidylprolyl isomerase F, a mitochondrial protein found to be involved in ischemia/reperfusion-induced cell death, 254 the calcitonin gene-related peptide 2, a vasodilator that increases susceptibility to AKI, 255 and superoxide dismutase 3, an extracellular oxidoreductase that decreases oxidative stress and injury after ischemia/ reperfusion-induced AKI. 256 The connection of all gap-bridging proteins to AKI was interpreted as a sign for the high integrity of the molecular interaction graph.…”
Section: Q36mentioning
confidence: 99%
“…Computational methods, such as bi-clustering ( Pontes et al, 2015 ), are used to create co-expressed gene sets, which consist of genes whose expression pattern is correlated across a set of chemical exposure conditions. In our initial efforts, we used the Iterative Signature Algorithm ( Bergmann et al, 2003 ) to identify co-expressed gene sets (modules) associated with molecular toxicity pathways and link them to specific injuries in the liver and kidney ( Tawa et al, 2014 ; AbdulHameed et al, 2016 ). Our injury modules were selectively activated by chemical insults.…”
Section: Introductionmentioning
confidence: 99%
“…Other studies have addressed various questions of applying TGx including optimal treatment duration and sample size for a better predictive performance ( Liu et al, 2011 ; Gusenleitner et al, 2014 ; Matsumoto et al, 2015 ; Liu S. et al, 2017 ). TGx has also been used in semi-quantitative risk assessment such as defining points of departure and benchmark dosing ( Yang et al, 2007 ; AbdulHameed et al, 2016 ; Chauhan et al, 2016 ; Dean et al, 2017 ; Farmahin et al, 2017 ; Kawamoto et al, 2017 ). Most widely used application of TGx approaches is to understand the molecular mechanisms of different toxicological endpoints ( Ellinger-Ziegelbauer et al, 2008 ; Blomme et al, 2009 ; Rodrigues et al, 2016 ; Hendrickx et al, 2017 ; Rueda-Zárate et al, 2017 ).…”
Section: Introductionmentioning
confidence: 99%